BECTON DICKINSON & CO
About BECTON DICKINSON & CO
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $21.8B
- Net income
- $1.7B
- Total assets
- $55.3B
- Market cap
- $41.7B
- Gross margin
- 45.4%
- Operating margin
- 11.8%
- Net margin
- 7.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $21.8B
- Cost of revenue
- $11.9B
- Gross profit
- $9.9B
- Operating expenses
- $7.3B
- Operating income
- $2.6B
- Income tax
- $203.0M
- Net income
- $1.7B
- EPS (basic)
- $5.83
- EPS (diluted)
- $5.82
Balance sheet
- Total assets
- $55.3B
- Current assets
- $9.3B
- Total liabilities
- $29.9B
- Current liabilities
- $8.3B
- Shareholders’ equity
- $25.4B
Cash flow
- Operating cash flow
- $3.4B
- Investing cash flow
- -$818.0M
- Financing cash flow
- -$3.6B
- Net cash flow
- -$1.0B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $41.7B
- P/E ratio
- 25.8
- EPS (diluted)
- $5.82
- Dividend yield
- 2.8%
- Shares outstanding
- 277.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 25, 1963
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $1.7B in FY2025.
- Revenue grew 28% from FY2020 to FY2025.
- Gross margin of 45.4%, net margin 7.7%.
- Trading 29% below its 52-week high.
- Pays a dividend yielding about 2.8% annually.
- Valued at a price-to-earnings (P/E) ratio of 25.8.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BECTON DICKINSON & CO.
Write a review
News about BECTON DICKINSON & CO
News & sentiment via Polygon.io
